

Ramkumar Mandalam
















Ramkumar Mandalam, Ph. D








Ramkumar Mandalam, Ph. D. is the President (2003-5) and Charter Member of EPPIC. Ram Mandalam is the Vice President of Pharmaceutical Operations at Cellerant Therapeutics, responsible for overseeing the development, manufacturing, and quality systems of Cellarant's products and contributing to the clinical management team in support of company's clinical trials. Prior to joining Cellerant, Ram was the Executive Director of Product Development at Geron Corporation, where he managed development and manufacturing of cell-based therapies for degenerative diseases and cancer. 

Dr. Mandalam's expertise and interest is in the areas of R & D, manufacturing and commercialization of human cellular products and biopharmaceuticals. Prior to joining Geron in 2000, he was the Director of Development Research at Aastrom Biosciences where he led research and development programs involving ex vivo expansion of human primary cells (including bone marrow and cord blood cells) for cell therapy applications. 

Dr. Mandalam's experience includes managing external collaborations and corporate alliances, participation in merger and acquisition discussions, and grant submissions, Dr. Mandalam received his Ph. D in Chemical Engineering from University of Michigan, Ann Arbor.











    Ramkumar Mandalam | Cellerant Therapeutics Inc | ZoomInfo.com

Ramkumar Mandalam, Cellerant Therapeutics Inc: Profile & Biography - Bloomberg


































































  






















Feedback





Ramkumar Mandalam

President/CEO,
Cellerant Therapeutics Inc






Career History




President/CEO
Cellerant Therapeutics Inc, 2005-PRESENT


Director:Product Development
Geron Corp, 2005-UNKNOWN









Website:
www.cellerant.com






Corporate Information
Address:

1561 Industrial Road
San Carlos, CA 94070
United States


Phone:
1-650-232-2122


Fax:
1-650-232-5495


Web url:
www.cellerant.com











From The Web












Personal Information



Education



University of Michigan
PhD








Memberships



Board Memberships




Cryoport Inc


Board Member, 6/2014-PRESENT









Sponsored Financial Commentaries







More From The Web


















Home


News


Top Headlines
Most Popular
Exclusive
Law
Entrepreneurs
Leaders
Economy
Environment
Science
Sports
Markets Magazine
Pursuits Magazine
Bloomberg Visual Data
Bloomberg Best (and Worst)
For comments or complaints about news coverage click here


Regions
U.S.
China
Europe
Asia
U.K. & Ireland
Australia & New Zealand
Canada
India & Pakistan
Japan
Africa
Eastern Europe
Latin America
Middle East
Markets
Commodities
Currencies
Bonds
Stocks
Energy Markets
Municipal Bonds
Emerging Markets
Funds
Islamic Finance
Industries
Energy
Technology
Real Estate
Finance
Health Care
Transportation
Insurance
Retail
Media
Manufacturing




Quick


Market Data


Stocks
Stock Futures
World Indexes
Americas
Europe, Middle East, & Africa
Asia-Pacific
Gainers & Losers
Earnings Calendar
Industry Leaders
Currencies
Americas
Europe, Middle East, & Africa
Asia-Pacific
Foreign Exchange Cross Rates
FX Fixings
Currency Converter
Forex Trading Videos
Commodities
Energy Prices
Metals Prices
Agricultural Prices


Rates & Bonds
US Treasuries
UK Gilts
Germany Bunds
Japan Bonds
Australia Bonds
Bloomberg Bond Indexes
Corporate Bonds
Consumer Rates
Economic Calendar
Watchlist
European Debt Crisis
Symbol Search
The Market Now




Personal Finance


Top Headlines
Saving & Investing
Real Estate
Retirement Planning
Financial Advisers
Taxes
Blog: Ventured & Gained
Real Cost Of
Money Gallery
Calculators
Watchlist (Portfolio Tracker)




Tech


Top Headlines
Social Media
Mobile & Wireless
Web
Enterprise Tech
TV, Games & Movies
Apple
Tech Deals
Global Tech
Slideshows
Videos




U.S. Politics


Sustainability


Top Headlines
Energy
Corporate Sustainability
Policy
Natural Resources
Health & Population
Slideshows
Videos
Blog: The Grid




Luxury


Top Headlines
Autos
Billionaires
Living
Property
Travel
Well Spent
Loot Blog
Pursuits Magazine
Videos




TV


Live TV
Channel Finder
Personalities
Apple TV
iPad App
Schedule
U.S.
Asia
Europe


Shows
Surveillance
Market Makers
Lunch Money
Street Smart
Bloomberg West
Game Changers




Video


Must See
Latest
Live TV
Shows
Playlist




Radio


Live Radio
Shows
Schedule
Personalities
Podcasts
Bloomberg Brief
Featured Podcasts and New Shows
Bloomberg View
Masters in Business
First Word
Surveillance
Bloomberg Advantage
In the Loop
Bloomberg Law
Taking Stock
Bloomberg Best
More Podcasts




Blogs


Global Tech
The Grid
Loot
The Market Now
Political Capital
Tech Deals
Ventured and Gained




Opinion




My Saved



Registration



Sign In



Bloomberg.com



Businessweek.com



Company



About
Blog
Careers
Diversity & Inclusion
News Mission
Philanthropy & Engagement
Press Room
Procurement
Sustainability




Products



Financial Products
Bloomberg Professional Service
Bloomberg Anywhere
Bloomberg Tradebook
Bloomberg Briefs
Bloomberg Indexes
Bloomberg SEF
Service Center
Customer Support
Enterprise Products
Enterprise Solutions
Trading Solutions
Industry Products
Bloomberg BNA
Bloomberg Government
Bloomberg Law
Bloomberg Link
Bloomberg New Energy Finance
Bloomberg Sports
Content Licensing




Bloomberg Anywhere



Mobile Apps



Bloomberg Visual Data






































Cryoport Announces Appointment of Ramkumar Mandalam, Ph.D. to  Board of Directors
















<img  height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">























































 Science. Logistics. Certainty.







Cryoportal Login Request a Quote Menu  


















Services
Why Cryoport

End-to-End Solutions
Steadfast Protection
Intelligent Logistics
Nonstop Monitoring
Complete Compliance
Risk Mitigation

Who We Serve

Biopharmaceutical
IVF
Animal Health

About Us

Partners
Management Team
Board of Directors
Careers
Locations

Resources
News & Events

Events
Articles
Blog
Press Releases

Investor Relations

Investor Story
Stock Information
News Releases
EVENTS & PRESENTATIONS
SEC FILINGS
ANALYST COVERAGE
Corporate Governance
INVESTOR FAQS
EMAIL ALERTS
Information Request

Contact Us

Contact Us
Request a Quote














   



















Cryoport News

















Cryoport Announces Appointment of Ramkumar Mandalam, Ph.D. to  Board of Directors


June 16, 2014



 
LAKE FOREST, CA – June 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading, global provider of advanced cryogenic logistics solutions, today announced the appointment of Ramkumar Mandalam, Ph.D., to its Board of Directors. Additionally, he has been appointed to serve as a member of the Compensation and Nominating and Governance Committees. Following Dr. Mandalam’s appointment, Cryoport’s Board of Directors will have a total of five members, including four independent members.           
   
“The need for an effective and efficient cryogenic transportation is critical to preserve the potency and viability of sensitive biological cellular materials that are being developed in the growing fields of Regenerative Medicine and Immunotherapy,” stated Dr. Mandalam. He continued, “Cryoport provides unique shipping solutions in a comprehensive, easy-to-use, economic, and reliable manner while addressing the time and temperature sensitivities of these materials. I am excited to join Cryoport’s Board and look forward to contributing to its continued growth. I am eager to work with the Company’s experienced management team and other board members as we look to further expand the market for cryogenic logistics for biologic materials.”
   
Jerrell Shelton, Chief Executive Officer of Cryoport, stated, "We welcome Dr. Mandalam to our Board. He brings invaluable industry expertise within the life sciences.  His extensive insights will allow us to better navigate our markets from our clients’ perspectives. We will benefit tremendously from his expertise as the already large and growing cryogenic logistics market becomes further enhanced by rapidly developing autologous and allogeneic therapies.” 
   
“I am delighted to welcome Dr. Mandalam to our Board,” commented Richard Rathmann, Chairman of the Board of Cryoport.  “Dr. Mandalam complements the Board with his experience and success in leading the development of complex biological products.  He will be a great asset to Cryoport as we strengthen our position as the premier global logistics provider in the cold chain.”   
   
Dr. Mandalam joins Cryoport’s Board with twenty years of experience in the development of biologics.  He is currently the President and Chief Executive Officer of Cellerant Therapeutics, Inc., a clinical stage biotechnology company developing cellular and antibody therapies for the treatment of hematological malignancies and blood related disorders.  Previously, Dr. Mandalam served as Executive Director of Product Development at Geron Corporation, where he managed the development and manufacturing of cell based therapies for treatment of degenerative diseases and cancer. Dr. Mandalam has also held positions of increasing responsibility at Aastrom Biosciences, most recently as Director of Developmental Research. Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan. He is the author or co-author of several publications, patent applications, and abstracts.
     
About Cryoport, Inc.
   
Cryoport provides leading edge cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, advanced information technology and highly skilled logistics expertise which manages the entire cold chain logistics process. Cryoport Express® liquid nitrogen dry vapor shippers are validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration, and its Cryoportal™ Logistics Management Platform assists in managing the entire logistics process, including initial order input, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport’s total turnkey logistics solutions offer reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a “green” and environmentally friendly solution. Cryoport service options include recording the “chain of condition” and “chain of custody” for all shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information visit www.cryoport.com.
 
Forward Looking Statements 
 
Statements in this press release which are not purely historical, including statements regarding Cryoport, Inc.’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, and technical development risks. The company’s business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2013. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise, any forward-looking statements in this press release.
   
Cryoport Contacts:  Todd Fromer / Garth Russell tfromer@kcsa.com / grussell@kcsa.com  P: 1-212-682-6300
 

 Tags:
                
                    Frozen Shipping,
                
                    shipping solution,
                
                    Frozen,
                
                    board,
                
                    Ramkumar Mandalam,
                
                    Ph.D.,
                
                    Cold Chain Logistics,
                
                    Dry Shipper,
                
                    cold shipping,
                
                    Clinical Trials Logistics















Share











Services
Why Cryoport

End-to-End Solutions
Steadfast Protection
Intelligent Logistics
Nonstop Monitoring
Complete Compliance
Risk Mitigation

Who We Serve

Biopharmaceutical
IVF
Animal Health

About Us

Partners
Management Team
Board of Directors
Careers
Locations

Resources
News & Events

Events
Articles
Blog
Press Releases

Investor Relations

Investor Story
Stock Information
News Releases
EVENTS & PRESENTATIONS
SEC FILINGS
ANALYST COVERAGE
Corporate Governance
INVESTOR FAQS
EMAIL ALERTS
Information Request

Contact Us

Contact Us
Request a Quote





























 Immudex Selects Cryoport to Manage Cold Chain Logistics of Biologic Samples and Proficiency Panels Worldwide


Cryoport Participates in the Cold Chain BioLogistics Summit on June 16-18th 2014 in San Diego 




















Contact us or request a quote.
U.S. • Netherlands • SingaporeSales • +1 949.232.1900  |   Support • +1 949.470.2300








































©2017 Cryoport Systems, Inc. All rights reserved.




Privacy Policy | Website Terms and Conditions


























Cryoportal Login Request a Quote











Services
Why Cryoport

End-to-End Solutions
Steadfast Protection
Intelligent Logistics
Nonstop Monitoring
Complete Compliance
Risk Mitigation

Who We Serve

Biopharmaceutical
IVF
Animal Health

About Us

Partners
Management Team
Board of Directors
Careers
Locations

Resources
News & Events

Events
Articles
Blog
Press Releases

Investor Relations

Investor Story
Stock Information
News Releases
EVENTS & PRESENTATIONS
SEC FILINGS
ANALYST COVERAGE
Corporate Governance
INVESTOR FAQS
EMAIL ALERTS
Information Request

Contact Us

Contact Us
Request a Quote







































































Attend Our Upcoming Webinar


Integrating Equipment Design, Logistics Processes and Real-Time Informatics: The Arrival of Quality by Design in Pharmaceutical Logistics
Tuesday, July 11 | 11 a.m., EDT
Register Now!






















































            Ramkumar Mandalam | IMAPAC Media        














































Home
What We Do

Business Conferences & Trade Fairs
Executive Trainings
Market Intelligence


Who We Are

Our Philosophy
Mission, Vision & Character
Our People


How We Give

Why Education?
Our Collective Impact
Our Heart


Join us

Why work for IMAPAC
Who we need
Current openings


Contact
 Contact 

















Ramkumar Mandalam















Upcoming Events

 
 6th Bioplasma World Asia  5 – 6 September 2017, Shanghai, China
Where Asia’s Plasma and Blood Products Industry Convene Annually
Running consecutively for 5 years, Bioplasma World Asia has firmly established itself as the most definitive and most important annual meeting place for the plasma products industry! Continuing the tradition and success of the past, this year too, the event will bring you fresh perspectives from Asian and Global experts on the industry’s most pressing topics.
.. Read More. 
 Cell Therapy World Asia 2017  19 – 20 September 2017, Seoul, South Korea
Cell Therapy World Asia 2017 is bringing together Asia’s best of best in cell therapy development and manufacturing. This will be the most targeted conference that will attract cell therapy companies in Asia to discuss and debate on best practices and innovations in this space.
.. Read More. 
 4th Annual Retirement Living & Senior Care Southeast Asia 2017  24- 26 October 2017, Kuala Lumpur,  Malaysia
Retirement Living & Senior Care Southeast Asia 2017 is tailored to bring together developers, operators, investors and service providers in the aged care sector to shape the way we view Southeast Asia’s high and middle senior housing market.


.. Read More. 
 4th Annual Retirement Living World India 2017  5 – 7 December 2017, Bengaluru, India 
4th Annual Retirement Living World India will be attended by retirement village developers, financiers, operators and aged care professionals from India and the rest of the world. It’s your one-stop solution to reach out to the region’s retirement living industry!
.. Read More. 
















































Biography of Ramkumar Mandalam - The Official Board 




















 

 


 


We use cookies to provide a better service. By continuing your navigation, you consent to their use. Learn more on Privacy Policy.










Business E-mail



Password


            Lost password        



 




Executive name, Job title...



Advanced Search
Tips














Biography of Ramkumar Mandalam
                Last update: 12 days ago            







Career

                                                                                Ramkumar Mandalam graduated from University of Michigan.                                                                                Ramkumar was Executive Director of Product Development at Geron Corporation, and in various positions of research and development at Aastrom Biosciences.                                                                                 Ramkumar Mandalam joined Cryoport in 2014.                                                

Ramkumar Mandalam is currently

Director - Cryoport


Cryoport (org chart)





Create an alert 
                   to follow the career of Ramkumar Mandalam.
					                



With Skype, Call Cryoport at +1 949... and ask for  Ramkumar Mandalam.                

Share









More information about Ramkumar Mandalam

Selected links



Ramkumar Mandalam - Director - Cryoport






Social Media

                    Ramkumar Mandalam on Google News, Twitter, LinkedIn, YouTube
View the pictures of Ramkumar Mandalam 



Add a new link about Ramkumar Mandalam 


Delete any non-relevant links for Ramkumar Mandalam 

Do you need to know more about Ramkumar Mandalam?
Extend your search. 



Get in Touch

                    Sorry, but Ramkumar Mandalam cannot be contacted yet through our email service. Please use our Premium/VIP service to join colleagues of Ramkumar Mandalam listed below. Here are a few tips for establishing great contacts.                


The colleagues of Ramkumar Mandalam
Company Colleagues

                            At Cryoport, Ramkumar Mandalam has 6 colleagues  who can be contacted including Jerrell Shelton (CEO), Richard Berman (Director)…                         






Industry Colleagues

                        In the Package/Freight Delivery industry, Ramkumar Mandalam has 2,183 colleagues in 231 companies located in 55 countries.                        882 executive movements have been recorded in the last 12 months.                        Learn more about Package/Freight Delivery.






Report an error
Update the org chart details of Ramkumar Mandalam.












The most constantly updated executive database.


Companies
Learn about your customers' org charts. Understand their industries and their competitors.

List of the companies
Statistics by industry



Executives
View the executives' biographies. Contact the executives through our email platform.

Most viewed Biographies
Contact an executive



Alerts
Receive alerts when important organizational changes happen.

Create an alert
Manage your alerts



Track your customers
Download our data in Excel on your PC. File your customers in folders. Add private notes.

Download our data
Meaning of key titles








Insert a relevant link about Ramkumar Mandalam.

How does this work?Those links are either provided by our members or search engines. By adding links, you help make this biography more complete. We appreciate the help!



URL of the page to add*
Text to display*
Add a link





Which links about Ramkumar Mandalam are irrelevant and should be deleted?

How does this work?Our links are provided by our members and by our search technology.  By deleting links, you help make this biography more relevant. We appreciate the help!




Ramkumar Mandalam - Director - Cryoport

     Suppress this link (It is not relevant).

Confirm



 


                    For each of our 763,349 listed executives,discover their exact rolesand their biographies.                

Free Test






		After three unsuccessful trials, for your security,your access has to be interrupted for 10 minutes.Many thanks for your appreciated understanding.Please contact us for any assistance at contact@theofficialboard.com.	
Close
















Ramkumar Mandalam Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Ramkumar Mandalam Ph.D.
Board Member at Cryoport, Inc.


View Full Profile
Are you Ramkumar Mandalam Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Ramkumar Mandalam Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Ramkumar Mandalam Ph.D.'s  network and community.
												FOLLOW changes in Ramkumar Mandalam Ph.D.'s employment and money-in-motion.
												CONNECT with Ramkumar Mandalam Ph.D. through your network of contacts.
												








Ramkumar Mandalam Ph.D.'s Executive Work History


Current


Board Member, 
Cryoport, Inc.


Past
To view Ramkumar Mandalam Ph.D.'s complete executive work history, sign up now
Age
52

 
 


Ramkumar Mandalam Ph.D.'s Biography



Ramkumar Mandalam, age 49, became a member of the Board in June 2014. He is member of the Compensation Committee and Governance and Nominating Committee. Mr. Mandalam is the President and CEO of Cellerant Therapeutics, Inc., a clinical stage biotechnology company developing novel cell-based and antibody therapies for cancer treatment and blood-related disorders. Prior to joining Cellerant in 2005, he was the Executive Director of Product Development at Geron Corporation, a biopharmaceutical company where he managed the development and manufacturing of cell based therapies for treatment of degenerative diseases and cancer. From 1994 to 2000, h ...
(Read More)

			Ramkumar Mandalam, age 49, became a member of the Board in June 2014. He is member of the Compensation Committee and Governance and Nominating Committee. Mr. Mandalam is the President and CEO of Cellerant Therapeutics, Inc., a clinical stage biotechnology company developing novel cell-based and antibody therapies for cancer treatment and blood-related disorders. Prior to joining Cellerant in 2005, he was the Executive Director of Product Development at Geron Corporation, a biopharmaceutical company where he managed the development and manufacturing of cell based therapies for treatment of degenerative diseases and cancer. From 1994 to 2000, he held various positions in research and development at Aastrom Biosciences, where he was responsible for programs involving ex vivo expansion of human bone marrow stem cells and dendritic cells. Mr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, Michigan. Mr. Mandalam is the author or co-author of several publications, patent applications, and abstracts.
		
Source: Cryoport, Inc. on 07/25/2014
		
	

 






Sign up for Equilar Atlas and view Ramkumar Mandalam Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Ramkumar Mandalam Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Ramkumar Mandalam Ph.D.'s  network and community.
												FOLLOW changes in Ramkumar Mandalam Ph.D.'s employment and money-in-motion.
												CONNECT with Ramkumar Mandalam Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Ramkumar Mandalam Ph.D.


















Ramkumar Mandalam Ph.D.'s Connections (7)





Sign up now to view Ramkumar Mandalam Ph.D.'s 7 connections »









Robert S. Stefanovich
Chief Financial Officer, Treasurer and Corporate Secretary and Former Principal Executive Officer, Cryoport, Inc.









Robert J. Hariri
Board Member, MYOS RENS Technology









Edward J. Zecchini
Board Member, Cryoport, Inc.









Jerrell W. Shelton
Dir., President and Chief Executive Officer, Cryoport, Inc.









Richard J. Berman
Board Member, Advaxis









Richard G. Rathmann
Former Board Member, Cryoport, Inc.









Steven L. Leatherman
Former Chief Commercial Officer, Cryoport, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









David J. O'Connor
President and CEO, The Madison Square Garden Company









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993















Cellerant Therapeutics
















Home



CLT-008 Myeloid Progenitor Cells
CLT-009 Megakaryoid Progenitor Cells
Myeloid-derived Suppressor Cells
Therapeutic Antibodies
Publications






Hematopoietic Stem Cell Biology
Cell Therapy Process Development
Cancer Stem Cell Biology






Management
Board of Directors
Investors






2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005



Careers



Company Address
Driving Directions
Map
































 

Management

Ram Mandalam, Ph.D. Ram Mandalam, our President & CEO, joined the company in 2005. Ram was previously Executive Director of Product Development at Geron Corporation, where he managed the development and manufacturing of cell based therapies for treatment of degenerative diseases and cancer. Prior to Geron, he was Director of Developmental Research at Aastrom Biosciences, where he was responsible for the research and development programs involving ex vivo expansion of human bone marrow stem cells and dendritic cells. Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan. Dr. Mandalam is the author or co-author of several publications,patent applications, and abstracts. He currently serves on the board of Cyroport.


 









Copyright ©2006-2016 Cellerant Therapeutics, Inc.










